CVS Flashcards

1
Q

Clinical approach to “sympathetic crashing acute pulmonary edema”

A

1) Nitrates (hydralazine is also an option, but it is less titratable and less predictable)
2) PEEP/NIPPV
3) Diuretics (IV Lasix)
4) Beta blocker (if HR > 150)
5) Transition to long-term antihypertensive (ie. labetalol and hydralazine)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Clinical approach to “symptomatic bradycardia”

A

1) Atropine
2) Pacing (Transcutaneous or TVP)
3) Chronotropy (epinephrine, dopamine, isoproterenol)
4) Calcium (if secondary to hyper-kalemia)
5) Insulin (for beta blocker/CCB overdose)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

how to manipulate pulmonary vascular resistance to “unload the right ventricle”

A
  1. maintain SpO2 >92% (Hypoxic pulmonary vasoconstriction is to be avoided)
  2. Avoid excessive PEEP. PPV/PEEP is transmitted to the pulmonary circulation, adds to afterload. Unless patient is refractory hypoxemia d/t ARDS and needs to be oxygenated
  3. Avoidance of hypercapnea. CO2 increases pulmonary arterial pressure and RV afterload
  4. Pulmonary vasodilators (nitric oxide, prostacycline, bosentan, sildenafil, milrinone, levosimendan)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Target electrolyte levels in the setting on an AMI

A
  1. iCa+ > 1.0 mmol/L (Low serum calcium is independently correlated with LV systolic dysfunction in CAD patients with and without AMI)
  2. K+ 3.5-4.5 mmol/L (in setting of ACS, hypokalemia defined as potassium levels <3.5 is associated with ventricular arrhythmias)
  3. Mg+ >1.0 mmol/L (low serum Mg levels may be associated with cardiac arrhythmias and sudden death. Magnesium has antiarrhythmic effects)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

NSTEMI treatment pathway

A
  1. “Dual anti platelet therapy” (ASA + P2Y12 inhibitors)
  2. Statin therapy (atorvastatin)
  3. Beta blockade (metoprolol)
  4. Nitrates (NTG)
  5. Systemic anticoagulation (heparin/LMWH)
  6. Maintain normoxia (SpO2 >90%)
  7. Optimize electrolytes (target normal range)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

treatment pathway for tamponade

A
  1. Optimize preload with a fluid bolus (remember that tamponade is OBSTRUCTIVE and not cardiogenic shock. obstructive shock patients are preload dependent d/t elevated RV afterload
  2. Augment rate: Allow tachycardia (in your CO equation your preload/afterload/contractility are all fucked so if you want to maintain MAP you’ll have to keep the HR a little bit higher)
  3. Improve Forward flow: Levophed (if they are in shock you’ll have to support their hemodynamics with vasopressors. levy is 1st line)
  4. Remove effusion: pericardiocentesis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

CO goals in aortic stenosis

A
  1. preload high (force blood through the tiny little hole)
  2. afterload normal
    3.HR low (prevent pulmonary edema/back flow)
  3. contractility high (force blood out)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

CO goals acute aortic regurgitation and acute mitral regurgitation

A
  1. afterload low
  2. HR high (dont allow backfill)
  3. contractility high (force blood out)
  4. PPV or Intubation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

CO goals acute mitral stenosis

A
  1. preload normal (Phenylephrine or vasopressin)
  2. afterload normal
  3. HR low (prevent pulmonary edema/back flow) [Esmolol or amiodarone]
  4. contractility normal
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

CO goals aortic stenosis

A
  1. give fluids/Avoid preload-decreasing drugs
  2. Vasopressors for cardiogenic shock (Phenylephrine or vasopressin)
  3. sensitive to both bradyarrhythmia and tachydysrhythmias (Treat both aggressively)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

ACS treatment pathway

A
  1. Dual antiplatelet therapy (Aspirin + P2Y12 inhibitor)
  2. Anticoagulant (UFH/enoxaparin/fondaparinux)
  3. Oxygen (sats >94%)
  4. Rate control (Metoprolol)
  5. Analgesia (NTG, opioids)
  6. Statin therapy
  7. Reperfusion (TnK or PCI)
  8. Angiotensin-converting enzyme inhibitors
  9. Optimize electrolytes (target normal range)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

PULMONARY EDEMA + SHOCK (“wet and cold” Cardiogenic Shock) treatment algorithm

A
  1. IV/O2/Monitor
  2. Differentiating the shock (pump failure vs mechanical complications)
  3. optimize the MAP (Norepinephrine +/-
    Inotropic agent)
  4. “fix the lungs” (CPAP/NIPPV/Intubation)
  5. differentiate + optimize volume status (fluid bolus vs lasix)
  6. consider inotrope for HFrEF/shitty contractility (dobutamine/epi)
  7. treat underlying etiology
  8. mechanical circulatory support
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

treatment goals for acute cardiogenic shock

A
  1. Address the underlying cause of shock
  2. If shock is from pump failure, patients are frequently extravascularly fluid-overloaded but intravascularly volume-depleted
  3. Fluid challenges in 250-mL isotonic crystalloid boluses with frequent re-assessment of intravascular volume status
  4. if patient is still hypotensive post fluids, start an adrenergic agonist (norepinephrine)
  5. Dobutamine is a good option for inotropy when the primary mechanism of shock is poor cardiac contractility. Patients may still require levo for hemodynamic support
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

treatment goals for Hypertensive acute decompensated HF

A
  1. Treatment should be targeted to afterload and preload reduction
  2. Afterload can be reduced with a number of medicines, including nitrates and ACE inhibitors
  3. Nitrates are first line, with NTG being the most common
  4. loop Diuretics can be used in intravascularly volume-overloaded patients for preload reduction (Lasix)
  5. Check and replenish electrolytes, particularly magnesium and potassium (arrhythmias)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

treatment for cardiogenic shock patients who are “warm and wet”

A
  1. Fix lungs (CPAP/BIPAP)
  2. Fix perfusion (Norepinephrine +/- inotrope)
  3. Determine volume status and address
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Acute HF treatment goals

A
  1. fix the lungs (O2 vs NIPPV vs Tube them)
  2. optimize perfusion (Levo support?)
  3. optimize volume status (fill the tank vs diurese)
  4. optimize contractility (inotrope? electrolytes?)
  5. treat underlying etiology (cath lab?)
  6. consider mechanical circulatory support (does this dude need IABP/ECMO/LVAD)
17
Q

hemodynamic strategies and targets in aortic dissection

A
  1. HR <60
  2. SPB <120 mm Hg
  3. art line for accurate titration of antihypertensives
  4. If BP differs between arms on NIBP use the extremity/value with the higher BP
  5. Labetalol IV 10-20 mg bolus over 2 min, then 20-80 mg bolus q10-15 min to a max of 300 mg, or initiate labetalol infusion at 0.5-2 mg/min, titrate up by 0.5 mg/min every 10 min to a max of 10 mg/min.
    might have to stack hydralazine on top of your labetalol to hit the alpha reduction
18
Q

Treatment for Post Cardiac Arrest

A
  1. Labs, EKG, POCUS, Imaging
  2. If MI then MI management, consider abx if infiltrates on CXR, replace magnesium as needed
  3. TTM, Video EEG, Avoid long acting sedatives (propofol prefered)
    Analgesia/antipyretic package:
    1,000 mg acetaminophen PO q6hr scheduled.
    Buspirone 30 mg PO q8hr-q12hr.
    Ketamine infusion 0.1-0.3 mg/hr is helpful for both analgesia and shivering.
  4. Finding the cause of the cardiac arrest is the most important thing.
  5. Hemodynamic targets as per normal